by Stephanie Holmes | Dec 17, 2020 | Lupus Foundation of America
The U.S. Food and Drug Administration (FDA) has approved Benlysta® to treat lupus nephritis (lupus-related kidney disease) in adults. The approval is for both the intravenous and subcutaneous formulations. The decision makes Benlysta the first lupus therapy authorized...
by | Dec 17, 2020 | Lupus Foundation of America
The U.S. Food and Drug Administration (FDA) has approved Benlysta® to treat lupus nephritis (lupus-related kidney disease) in adults. The approval is for both the intravenous and subcutaneous formulations. The decision makes Benlysta the first lupus therapy authorized...
by Suzanne Tierney | Dec 10, 2020 | Blog, Lupus Foundation of America
It is an ugly stormy morning. All night, the rain hit the windows and the trees smacked against each other. The dark gloomy skies and the bold blasts of thunder were enough to make anyone want to hide under their blanket. It starts with a headache, then overall body...
by Stephanie Holmes | Dec 8, 2020 | Lupus Foundation of America
At its annual membership meeting today, which was the culmination of a year-long celebration of the organization’s 100th Anniversary, the National Health Council (NHC) elected its officers and new members of the Board of Directors for 2021. Diana Gray, MA, President...
by Stephanie Holmes | Dec 8, 2020 | Lupus Foundation of America
At its annual membership meeting today, which was the culmination of a year-long celebration of the organization’s 100th Anniversary, the National Health Council (NHC) elected its officers and new members of the Board of Directors for 2021. Diana Gray, MA, President...
by Stephanie Holmes | Dec 7, 2020 | Lupus Foundation of America
If we have learned anything in 2020, it’s to adapt to change. While the coronavirus pandemic put traditional endurance races to a halt, that didn’t stop Team Make Your Mark! In September, 500 participants across the country, as well as in Canada and the UK,...
